#USA #Düsseldorf #Rockwell Automation #PharmaSuite #Sintetica

Sintetica's Digital Transformation Journey with PharmaSuite MES

In an era characterized by rapid digital transformation, Sintetica SA, a Swiss pharmaceutical supplier, is making significant strides in enhancing its operational efficiency and product quality. The adoption of FactoryTalk® PharmaSuite® manufacturing execution system (MES) from Rockwell Automation marks a pivotal development in Sintetica's ongoing digitalization initiative. The aim? To improve overall quality, enhance monitoring capabilities, and accelerate time to market for its innovative pharmaceutical products.

Founded in 1921, Sintetica specializes in developing therapies for anesthesia, pain management, intensive care, and neuromodulation—areas that demand the highest levels of precision and reliability. By leveraging the capabilities of PharmaSuite, Sintetica is set to refine its production processes while ensuring compliance with stringent regulatory standards.

Roger Gaemperle, EMEA head of industry strategy and marketing for life sciences at Rockwell Automation, states, "Pharmaceutical companies face increasing pressure—not only from consumers but also from regulatory bodies. Establishing a robust digital foundation at the start of any production operation facilitates faster access to critical insights throughout the value chain. This is where PharmaSuite MES delivers substantial value for our pharmaceutical clients."

The collaboration between Rockwell Automation and Sintetica began with the design and implementation phases of PharmaSuite MES. Rockwell's consultants worked closely with Sintetica to tailor the software to its specific needs, a process made easier by the software's flexibility. This adaptability allowed for modifications that could respond to Sintetica's evolving requirements, ensuring that they are well-equipped for future challenges.

Since its initial rollout on two production lines, the feedback from Sintetica's operators has been overwhelmingly positive. Employees have noted how the data-driven insights provided by PharmaSuite have empowered them, significantly reducing the time previously spent on monitoring and managing essential batch information and operational logs. This positive reception is a direct reflection of a successful deployment that prioritizes user experience and operational efficacy.

"Our journey towards digital transformation is a path of self-improvement," explains Pierluigi De Rosa, application manager at Sintetica overseeing digital affairs. He adds, "We are driven by the ambition to become more efficient throughout our production operations, while simultaneously enhancing both our quality assurance processes and compliance programs with regulatory requirements. Although we are not yet utilizing PharmaSuite across all product lines, it is playing a critical role during the preparation phase for most production projects, providing a strong and accurate foundation for all future initiatives."

PharmaSuite not only simplifies batch recording but also enhances traceability, allowing Sintetica to respond promptly to any production discrepancies while maintaining peak operational performance. As industries continue to evolve, the integration of advanced manufacturing technologies like PharmaSuite becomes crucial for remaining competitive and meeting the ever-increasing demands of the pharmaceutical market.

In summary, Sintetica's adoption of PharmaSuite MES highlights the vital importance of digitalization in the pharmaceutical industry. By harnessing this technology, Sintetica is not only optimizing its production processes but also reinforcing its commitment to quality, compliance, and ultimately, the well-being of patients who rely on its innovative therapies. With such tools at their disposal, Sintetica is poised to navigate the complexities of modern pharmaceutical manufacturing with greater confidence and resilience than ever before.